Related Experiment Videos
Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema
R J Couser1, T B Ferrara, B Falde
1Division of Neonatology, Minneapolis Children's Medical Center, Minnesota.
Insights
Prophylactic dexamethasone significantly reduces postextubation stridor and respiratory distress in high-risk preterm infants. This corticosteroid therapy improves pulmonary function and decreases reintubation rates, offering a vital preventative strategy.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Preterm infants undergoing prolonged or traumatic endotracheal intubation are at high risk for airway edema.
- Postextubation stridor and respiratory distress pose significant challenges in neonatal intensive care.
Purpose of the Study:
- To evaluate the efficacy of prophylactic dexamethasone in preventing postextubation stridor and respiratory distress.
- To assess the impact of dexamethasone on pulmonary function and reintubation rates in high-risk preterm infants.
Main Methods:
- Prospective, randomized, controlled clinical trial involving 50 high-risk preterm infants.
- Dexamethasone group (n=27) received 0.25 mg/kg doses every 8 hours for three doses; control group (n=23) received saline.
- Pulmonary function tests, blood gas studies, and physical examinations were performed at baseline and post-extubation.
Main Results:
- Dexamethasone group showed a significantly lower increase in total pulmonary resistance (33% vs. 225%) post-extubation.
- Treated infants had improved tidal volume, dynamic compliance, and lower arterial carbon dioxide pressure.
- Postextubation stridor occurred in 2/27 dexamethasone-treated infants versus 10/23 controls (p < 0.006).
- Reintubation was required in 0/27 treated infants compared to 4/23 controls (p < 0.05).
Conclusions:
- Prophylactic dexamethasone is effective in preventing postextubation stridor and respiratory distress in high-risk preterm infants.
- Corticosteroid therapy improves pulmonary mechanics and reduces the need for reintubation in this vulnerable population.
Abstract:
We studied 50 preterm infants who had multiple or traumatic endotracheal intubations, or whose duration of endotracheal intubation was > or = to 14 days, and who were considered at high risk for airway edema. These infants were enrolled in a prospective, randomized, controlled clinical trial to assess whether prophylactic dexamethasone therapy would be effective in the prevention of postextubation stridor and respiratory distress. At study entry, both groups had similar weights, postnatal ages, methylxanthine use, ventilator settings, blood gas values, and pulmonary function test results (dynamic compliance, total respiratory resistance, tidal volume, peak-to-peak transpulmonary pressure, minute ventilation, and peak inspiratory and expiratory flow rates). Patients underwent blood gas studies, physical examinations, and pulmonary function testing at baseline (4 hours before extubation) and again 2 to 4 hours and 18 to 24 hours after extubation. Twenty-seven infants received dexamethasone, 0.25 mg/kg per dose, at baseline, and then every 8 hours for a total of three doses; 23 infants received saline solution at corresponding times. Eighteen to twenty-four hours after extubation, total pulmonary resistance increased by 225% from baseline in the control group compared with 33% in the dexamethasone group (p < 0.006), and the dexamethasone group had a greater tidal volume, a greater dynamic compliance, and a lower arterial carbon dioxide pressure. Of 23 control infants, 10 had postextubation stridor compared with 2 of 27 dexamethasone-treated patients (p < 0.006). Of the 23 control patients, 4 required reintubation compared with none of the treated group (p < 0.05). We conclude that the prophylactic use of corticosteroids for the prevention of postextubation stridor and respiratory distress is efficacious in low birth weight, high-risk preterm infants.